Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2008
06/26/2008CA2672813A1 Device and method for monitoring the particle contamination in flowing hydraulic fluids
06/26/2008CA2672784A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1
06/26/2008CA2672491A1 Enhanced downhole fluid analysis
06/26/2008CA2672380A1 Yeast platform construction and screening methods
06/26/2008CA2672315A1 Methods and apparatus for measuring analytes using large scale fet arrays
06/26/2008CA2671939A1 Cancer biomarkers
06/26/2008CA2671431A1 Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
06/26/2008CA2670568A1 Lateral flow assay device and absorbent article containing same
06/26/2008CA2670526A1 Indicator immobilization on assay devices
06/26/2008CA2670519A1 Enzyme detection techniques
06/26/2008CA2670516A1 Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an antiinflammatory and/or anticoagulatory agent
06/26/2008CA2670020A1 Devices, systems, methods and tools for continuous glucose monitoring
06/26/2008CA2668779A1 Microfluidic system and method to test for target molecules in a biological sample
06/26/2008CA2645159A1 Multiplex protein fractionation
06/25/2008EP1936381A1 Ptpase inhibitors and method of using same
06/25/2008EP1936380A1 Placental growth factor, soluble FLT1 and endoglin are predictors of the angiogenic status of a subject
06/25/2008EP1936379A1 Method for the detection of active hpv infection in biological samples by a sandwich enzyme-linked immunosorbent assay and test kit for performing the method
06/25/2008EP1936378A1 Nanoparticle biosensor, method of preparing same and uses thereof
06/25/2008EP1936377A1 Method for detection of cAMP and cGMP
06/25/2008EP1936376A2 Screening and treatment methods for prevention of preterm delivery
06/25/2008EP1936375A1 Non-enzymatic disposable electrode strip comprising a surfactant for detecting uric acid or hemoglobin; method for producing the same and its use
06/25/2008EP1936374A1 Analysis hand-held device with conveyor path for analytical consumables
06/25/2008EP1936373A1 Test fluid measurement device and sensitivity calibration method thereof
06/25/2008EP1936372A1 Non-specific adsorption inhibitor, probe-bonded particles, and method for producing the same
06/25/2008EP1936371A1 Exhaust gas measuring bag
06/25/2008EP1936370A1 Determination and prediction of the expression of traits of plants from the metabolite profile as a biomarker
06/25/2008EP1936368A2 Accoustic nondestructive testing of cement
06/25/2008EP1936351A2 A method and a system for determination of particles in a liquid sample
06/25/2008EP1936350A1 A method for quantitatively measuring agglutination parameters
06/25/2008EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection
06/25/2008EP1935990A2 Apparatus having reduced noise and method of using the apparatus for detecting ionic materials
06/25/2008EP1935985A1 Method of detecting reactive metabolite
06/25/2008EP1935983A2 Method for determination of biological particles in blood
06/25/2008EP1935979A2 Antigenic meningococcal peptides
06/25/2008EP1935903A1 A method for preserving human cell membrane antigen and human cell membrane antigen coated with magnetic particle
06/25/2008EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use
06/25/2008EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
06/25/2008EP1935496A1 Device and/or method for the detection of amplified nucleotides sequences on micro-arrays
06/25/2008EP1935491A1 Microchannel chip comprising a reagent in a heat soluble binder
06/25/2008EP1935484A2 Oligomer probe array chip, related mask and analysis method
06/25/2008EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule
06/25/2008EP1935347A1 Method of analyzing for at least one allergy
06/25/2008EP1935331A2 Process for the preparation of modified electrodes, electrodes prepared with said process, and enzymatic biosensors comprising said electrodes
06/25/2008EP1935244A1 Animal model of schizophrenia
06/25/2008EP1935003A2 Discretized processing and process sequence integration of substrate regions
06/25/2008EP1934618A2 Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (adsmb)
06/25/2008EP1934617A1 Process of screening a molecule as a candidate drug for the treatment of bipolar disorder
06/25/2008EP1934616A1 Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
06/25/2008EP1934615A2 Methods and materials for identifying the origin of a carcinoma of unknown primary origin
06/25/2008EP1934613A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (mrsa) of mrej types xi to xx
06/25/2008EP1934612A1 Anti-ccp and antinuclear antibodies in diagnosis of rheumatoid arthritis
06/25/2008EP1934611A2 Vhh for the diagnosis, prevention and treatment of diseases associated with protein aggregates
06/25/2008EP1934610A1 Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)
06/25/2008EP1934609A1 Magnetic nanoparticle having fluorescent and preparation method thereof and use thereof
06/25/2008EP1934608A2 Targeted identification of immunogenic peptides
06/25/2008EP1934607A1 Multiplex in situ immunohistochemical analysis
06/25/2008EP1934606A2 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators
06/25/2008EP1934604A1 Materials and methods for assaying for glyoxylate
06/25/2008EP1934603A2 Biomarker for prostate cancer
06/25/2008EP1934602A1 Method for detecting a biomarker of oxidative stress in a biological sample
06/25/2008EP1934601A1 Genetic selection system to identify proteases, protease substrates and protease inhibitors
06/25/2008EP1934600A2 Kinetic biomarker for quantification of lymphoproliferation, clonal expansion, recruitment and trafficking in lymphoid tissues and of the in vivo actions of antigens and modulating agents thereon
06/25/2008EP1934599A1 Egfr dependent modulation of chemokine expression and influence on therapy and diagnosis of tumors and side effects thereof
06/25/2008EP1934598A2 Treatment and diagnosis of obligate intracellular pathogens
06/25/2008EP1934597A1 Standard moisture correction
06/25/2008EP1934596A1 A measuring device and a method for determination of at least one chemical property in an oil and a data storing device obtainable by said method
06/25/2008EP1934595A2 Method and device for rapid testing of the quality of cereals, grits and flours by measuring the aggregation of gluten
06/25/2008EP1934594A2 An animal model for studying atherosclerotic lesions
06/25/2008EP1934591A1 Gated voltammetry
06/25/2008EP1934590A1 Gas sensor
06/25/2008EP1934589A2 Gas sensor
06/25/2008EP1934588A1 Method and apparatus for detecting moisture in building materials
06/25/2008EP1934581A1 Biosensor with optically matched substrate
06/25/2008EP1934566A1 Method and apparatus for measuring properties of board products
06/25/2008EP1934388A1 Method of drug design
06/25/2008EP1934378A2 Methods for diagnosing pancreatic cancer
06/25/2008EP1934377A2 Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
06/25/2008EP1934373A2 Salivary protein and rna for breast cancer detection
06/25/2008EP1934368A2 Means and methods for diagnosing atgl related disorders
06/25/2008EP1934367A1 Molecular method for diagnosis of prostate cancer
06/25/2008EP1934365A2 Liquid-phase galactose oxidase-schiff s assay
06/25/2008EP1934363A2 Recurrent gene fusions in prostate cancer
06/25/2008EP1934326A2 Devices and methods for magnetic enrichment of cells and other particles
06/25/2008EP1934262A1 Antibodies to complementary peptides of thrombin or portions thereof
06/25/2008EP1934259A2 Nanobodies and polypeptides against egfr and igf-ir
06/25/2008EP1934258A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
06/25/2008EP1934251A2 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation
06/25/2008EP1934244A2 Methods and compositions relating to anthrax spore glycoproteins as vaccines
06/25/2008EP1934211A1 Biocompatible n, n-disubstituted sulfonamide-containing fluorescent dye labels
06/25/2008EP1934170A1 Novel iminecalixarene derivatives and aminocalixarene derivatives, method of preparation thereof, and self-assembled monolayer prepared by the method, fixing method of oligo-dna by using the self-assembled monolayer, and oligo-dna chip prepared by the method
06/25/2008EP1933883A2 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
06/25/2008EP1933870A2 Treatment of b cell diseases using anti-germline antibody binding agents
06/25/2008EP1933864A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
06/25/2008EP1933817A2 Encoded microparticles
06/25/2008EP1933614A2 Sucrose biosensors and methods of using the same
06/25/2008EP1848823A4 Methods for separating short single-stranded nucleic acid from long single- and double-stranded nucleic acid, and associated biomolecular assays
06/25/2008EP1815250A4 Disposable immunodiagnostic test system
06/25/2008EP1754971B1 Rapid diagnostic strip comprising a moisture-absorbing material and the blister packaging thereof
06/25/2008EP1754041A4 Method and device for rapid detection and quantitation of macro and micro matrices
06/25/2008EP1718772A4 Catalytic production of biomarkers from biological materials